A six-month supplementation of mulberry, Korean red ginseng, and banaba decreases biomarkers of systemic low-grade inflammation in subjects with impaired glucose tolerance and type 2 diabetes

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Kim, H J ^a   Yoon, K H ^b   Kang, M J ^b   Yim, H W ^b   Lee, K S ^c   Vuksan, V ^d   Sung, M K ^a  

^a Sookmyung Women's University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c National Agricultural Cooperative Federation   (South Korea)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BANABA EXTRACT; BIOLOGICAL MARKER; GINSENG EXTRACT; GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; MULBERRY EXTRACT; OXIDIZED LOW DENSITY LIPOPROTEIN; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BANABA; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG SYNTHESIS; FEMALE; GINSENG; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; MULBERRY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

EID: 84863272860     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/735191     Document Type: Article

References (36)

1. Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030 Diabetes Care 2004 27 5 1047 1053 (Pubitemid 38579764)
2. Jessani S., Millane T., Lip G. Y., Vascular damage in impaired glucose tolerance: an unappreciated phenomenon? Current Pharmaceutical Design 2009 15 29 3417 3432
3. Amini M., Horri N., Zare M., Haghighi S., Hosseini S. M., Aminorroaya A., Hovsepian S., People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients Annals of Nutrition and Metabolism 2010 56 4 267 272
4. Andersson C. X., Gustafson B., Hammarstedt A., Hedjazifar S., Smith U., Inflamed adipose tissue, insulin resistance and vascular injury Diabetes/Metabolism Research and Reviews 2008 24 8 595 603
5. Guilherme A., Virbasius J. V., Puri V., Czech M. P., Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes Nature Reviews Molecular Cell Biology 2008 9 5 367 377 (Pubitemid 351574198)
6. Shulman G. I., Cellular mechanisms of insulin resistance Journal of Clinical Investigation 2000 106 2 171 176 (Pubitemid 30483118)
7. de Luca C., Olefsky J. M., Inflammation and insulin resistance FEBS Letters 2008 582 1 97 105 (Pubitemid 50010731)
8. Semenkovich C. F., Insulin resistance and atherosclerosis Journal of Clinical Investigation 2006 116 7 1813 1822 (Pubitemid 44033301)
9. Monnier L., Mas E., Ginet C., Michel F., Villon L., Cristol J. P., Colette C., Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes Journal of the American Medical Association 2006 295 14 1681 1687
10. Vuksan V., Sung M. K., Sievenpiper J. L., Stavro P. M., Jenkins A. L., Di Buono M., Lee K. S., Leiter L. A., Nam K. Y., Arnason J. T., Choi M., Naeem A., Korean red ginseng (panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety Nutrition, Metabolism and Cardiovascular Diseases 2008 18 1 46 56 (Pubitemid 350297892)
11. Park M. Y., Lee K. S., Sung M. K., Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-, PPAR-, and LPL mRNA expressions Life Sciences 2005 77 26 3344 3354
12. Chen F., Nakashima N., Kimura I., Kimura M., Asano N., Koya S., Potentiating effects on pilocarpine-induced saliva secretion, by extracts and N-containing sugars derived from mulberry leaves, in streptozotocin diabetic mice Biological Pharmaceutical Bulletin 1985 18 12 1676 1680
13. Klein G., Kim J., Himmeldirk K., Cao Y., Chen X., Antidiabetes and anti-obesity activity of Lagerstroemia speciosa Evidence-based Complementary and Alternative Medicine 2007 4 4 401 407
14. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 2003 26 supplement 1 S5 S20
15. Matthews D. R., Hosker J. P., Rudenski A. S., Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 1985 28 7 412 419 (Pubitemid 15018832)
16. Temelkova-Kurktschiev T., Siegert G., Bergmann S., Henkel E., Koehler C., Jaro W., Hanefeld M., Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes Metabolism 2002 51 6 743 749 (Pubitemid 34624841)
17. Festa A., D'Agostino R., Howard G., Mykknen L., Tracy R. P., Haffner S. M., Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS) Circulation 2000 102 1 42 47 (Pubitemid 30430551)
18. Ross R., Atherosclerosisan inflammatory disease The New England Journal of Medicine 1999 340 115 126
19. Schaan B. D., Portal V. L., de Ugarte M. T. O., Dias A. A., Hatem D. M., Emerging risk factors and early atherosclerosis indices in subjects with impaired glucose tolerance Diabetes and Metabolism 2005 31 6 581 587 (Pubitemid 43001176)
20. Hu F. B., Stampfer M. J., Haffner S. M., Solomon C. G., Willett W. C., Manson J. E., Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes Diabetes Care 2002 25 7 1129 1134 (Pubitemid 41071162)
21. Meigs J. B., Hu F. B., Rifai N., Manson J. E., Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus Journal of the American Medical Association 2004 291 16 1978 1986 (Pubitemid 38544279)
22. Njajou O. T., Kanaya A. M., Holvoet P., Connelly S., Strotmeyer E. S., Harris T. B., Cummings S. R., Hsueh W. C., Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the health, aging and body composition study Diabetes/Metabolism Research and Reviews 2009 25 8 733 739
23. Matsuzawa-Nagata N., Takamura T., Ando H., Nakamura S., Kurita S., Misu H., Ota T., Yokoyama M., Honda M., Miyamoto K. I., Kaneko S., Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity Metabolism 2008 57 8 1071 1077 (Pubitemid 351978066)
24. Kersten S., Seydoux J., Peters J. M., Gonzalez F. J., Desvergne B., Wahli W., Peroxisome proliferator-activated receptor mediates the adaptive response to fasting Journal of Clinical Investigation 1999 103 11 1489 1498
25. Nakhjavani M., Asgharani F., Khalilzadeh O., Esteghamati A., Ghaneei A., Morteza A., Anvari M., Oxidized low-density lipoprotein is negatively correlated with lecithin-cholesterol acyltransferase activity in type 2 diabetes mellitus The American Journal of the Medical Sciences 2010
26. Reddy J. K., Hashimoto T., Peroxisomal -oxidation and peroxisome proliferatoractivated receptor : an adaptive metabolic system Annual Review of Nutrition 2001 21 193 230 (Pubitemid 32695270)
27. Jung Y., Song S., Choi C., Peroxisome proliferator activated receptor gamma agonists suppress TNFalpha-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species Immunology Letters 2008 117 1 63 69
28. Montezano A. C., Amiri F., Tostes R. C., Touyz R. M., Schiffrin E. L., Inhibitory effects of PPAR- on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats Journal of the American Society of Hypertension 2007 1 2 150 160 (Pubitemid 46696614)
29. Defronzo R. A., Banerji M. A., Bray G. A., Buchanan T. A., Clement S., Henry R. R., Kitabchi A. E., Mudaliar S., Musi N., Ratner R., Reaven P., Schwenke D. C., Stentz F. D., Tripathy D., Determinants of glucose tolerance in impaired glucose tolerance at baseline in the actos now for prevention of diabetes (ACT NOW) study Diabetologia 2010 53 3 435 445
30. Wolever T. M. S., Mehling C., Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance American Journal of Clinical Nutrition 2003 77 3 612 621 (Pubitemid 36258570)
31. Tarirai C., Viljoen A. M., Hamman J. H., Herb-drug pharmacokinetic interactions reviewed Expert Opinion on Drug Metabolism and Toxicology 2010 6 12 1515 1538
32. Yuan C. S., Wei G., Dey L., Karrison T., Nahlik L., Maleckar S., Kasza K., Ang-Lee M., Moss J., Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial Annals of Internal Medicine 2004 141 1 23 27
33. Shader R. I., Greenblatt D. J., Bees, ginseng and MAOIs revisited Journal of Clinical Psychopharmacology 1988 8 4 235
34. Fang S. H., Hou Y.-C., Chao P.-D., Pharmacokinetic and pharmacodynamic interactions of morin and cyclosporin Toxicology and Applied Pharmacology 2005 205 1 65 70 (Pubitemid 40693270)
35. Nagai M., Fukamachi T., Tsujimoto M., Ogura K., Hiratsuka A., Ohtani H., Hori S., Sawada Y., Inhibitory effects of herbal extracts on the activity of human sulfotransferase isoform sulfotransferase 1A3 (SULT1A3) Biological and Pharmaceutical Bulletin 2009 32 1 105 109
36. Karami-Mohajeri S., Abdollahi M., Toxic influence of organophosphate, carbamate, and organochlorine pesticides on cellular metabolism of lipids, proteins, and carbohydrates: a systematic review Human and Experimental Toxicology 2011 30 9 1119 1140